plot digitizer software getdata graph digitizer (GetData Pty Ltd)
90
Structured Review
GetData Pty Ltd
plot digitizer software getdata graph digitizer
Plot Digitizer Software Getdata Graph Digitizer, supplied by GetData Pty Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plot+digitizer+software+getdata+graph+digitizer/getdata+graph+digitizer/pmc09011241-114-40-43
Average 90 stars, based on 1 article reviews
Plot Digitizer Software Getdata Graph Digitizer, supplied by GetData Pty Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plot+digitizer+software+getdata+graph+digitizer/getdata+graph+digitizer/pmc09011241-114-40-43
Average 90 stars, based on 1 article reviews
plot digitizer software getdata graph digitizer - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Extraction:Article Title: Copanlisib plus rituximab combination therapy vs. rituximab monotherapy for relapsed indolent non-Hodgkin lymphoma: a cost-effectiveness analysis Article Snippet: .. Statistical analysis Data extraction and model fitting The original patient level data of this clinical trial was not directly available, so we extracted the picture of PFS and OS from the CHRONOS-3 trial, then reconstructed individual patient data (IPD) using Software:Article Title: Copanlisib plus rituximab combination therapy vs. rituximab monotherapy for relapsed indolent non-Hodgkin lymphoma: a cost-effectiveness analysis Article Snippet: .. Statistical analysis Data extraction and model fitting The original patient level data of this clinical trial was not directly available, so we extracted the picture of PFS and OS from the CHRONOS-3 trial, then reconstructed individual patient data (IPD) using Article Title: Copanlisib plus rituximab combination therapy vs. rituximab monotherapy for relapsed indolent non-Hodgkin lymphoma: a cost-effectiveness analysis Article Snippet: .. The original patient level data of this clinical trial was not directly available, so we extracted the picture of PFS and OS from the CHRONOS-3 trial, then reconstructed individual patient data (IPD) using |